These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3881202)

  • 41. The detection of basic and other drugs in urine bdistillation and UV spectrophotometry.
    Tompsett SL
    Clin Chem; 1969 Jul; 15(7):591-9. PubMed ID: 5794152
    [No Abstract]   [Full Text] [Related]  

  • 42. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay.
    Fraser AD
    J Anal Toxicol; 1987; 11(6):263-6. PubMed ID: 3323671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary amphetamines, benzodiazepines and methadone: cost-effective detection procedures.
    Moore FM; Jarvie DR; Simpson D
    Med Lab Sci; 1992 Mar; 49(1):27-33. PubMed ID: 1453905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of techniques used to detect drugs of abuse in urine: study based on external quality assessment.
    Wilson JF; Williams J; Walker G; Toseland PA; Smith BL; Richens A; Burnett D
    Clin Chem; 1991 Mar; 37(3):442-7. PubMed ID: 2004454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
    Cone EJ; Yousefnejad D; Dickerson SL
    J Forensic Sci; 1990 Jul; 35(4):786-91. PubMed ID: 2202774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of diphenydramine (Benadryl) metabolities in human subjects.
    Chang T; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):391-404. PubMed ID: 4445562
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacologic observations on 1,1-diphenyl-1 (dimethyl-aminoisopropyl)-butanone-2.
    HAAG HB; FINNEGAN JK; LARSON PS
    Fed Proc; 1947; 6(1):334. PubMed ID: 20343696
    [No Abstract]   [Full Text] [Related]  

  • 49. Specificity of the cannabinoid metabolite and phencyclidine EMIT d.a.u. assays.
    Allen LV; Stiles ML
    J Anal Toxicol; 1988; 12(1):45-7. PubMed ID: 3280873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Labetalol: false-positive indices by EMIT-d.a.u. assay and Toxi-Lab A urine screen.
    Apple FS; Googins MK; Kastner S; Nevala K; Edmondson S; Kloss J
    Clin Chem; 1985 Jul; 31(7):1250-1. PubMed ID: 3891145
    [No Abstract]   [Full Text] [Related]  

  • 51. Semiquantitation of cannabinoid immunoassays? A reexamination of the EMIT 20-ng/mL assay.
    Haver VM; Romson JL; Sadrzadeh SM
    J Anal Toxicol; 1991; 15(2):98-100. PubMed ID: 1646909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology and the clinical use of dolophine (6-dimethyl-amino-4,4-diphenyl 3-heptanone hydrochloride).
    KOHLSTAEDT KG; CLOUSE P
    Am J Med; 1947 Jul; 3(1):122. PubMed ID: 20343930
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification of diphenhydramine metabolites in human urine by capillary electrophoresis-ion trap-mass spectrometry.
    Baldacci A; Prost F; Thormann W
    Electrophoresis; 2004 Jun; 25(10-11):1607-14. PubMed ID: 15188248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AN ATTEMPT TO DEMONSTRATE CEILING EFFICACY OF ANALGESICS IN RATS.
    COLLINS RJ; WEEKS JR; MACGREGOR DW
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():76-82. PubMed ID: 14116944
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of phencyclidine by EMIT d.a.u. utilizing the ETS analyzer and a 25-ng/mL cutoff.
    Sneath TC; Jain NC
    J Anal Toxicol; 1992; 16(2):107-8. PubMed ID: 1501457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thin-layer chromatographic screening and confirmation of methadone and its primary metabolite in urine.
    Budd RD; Leung WJ
    Clin Toxicol; 1980 Mar; 16(1):55-9. PubMed ID: 7389281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutoff of 25 ng/mL for the EMIT d.a.u. phencyclidine assay.
    elSohly MA; Stanford DF
    J Anal Toxicol; 1990; 14(3):192-3. PubMed ID: 2197505
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evaluation of enzyme multiplied immunoassay technique for gentamicin assay. Comparison with bioassay].
    Sakata H; Takimoto M; Fujita Y; Kitsutaka T
    Jpn J Antibiot; 1982 May; 35(5):1229-32. PubMed ID: 6752460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gentamicin assay: comparison of an adapted EMIT method and an RIA method.
    Dols JL; van Zanten AP
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):236-9. PubMed ID: 7025734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.